期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

成人Burkitt淋巴瘤治疗进展 被引量：4

Therapeutics of Burkitt Lymphoma in Adults——Review
下载PDF
导出
摘要 Burkitt淋巴瘤是一种高度恶性的非霍奇金淋巴瘤。由于Burkitt淋巴瘤对化疗非常敏感,因此化疗依然是本病主要的治疗方案。生物制剂—利妥昔单克隆抗体的问世,使Burkitt淋巴瘤患者的总生存率有了明显的提高,而骨髓移植、手术治疗及局部放疗对于本病也有一定的辅助治疗作用。本文主要对Burkitt淋巴瘤的治疗及常用的化疗方案进行综述。 Burkitt lymphoma is a highly aggressive non-Hodgkin′s lymphoma.As Burkitt lymphoma cells are very sensitive to chemotherapy,chemotherapy is the major therapeutic schedule for this disease.Rituximab raised the overall survival rate markedly.Bone marrow transplant,surgery and radiotherapy also demonstrated to have a supporting role for patients with Burkitt lymphoma.This review focus on research progress of the therapeutics and major regimens for the disease.
作者 李丽 陈宝安
机构地区 东南大学医学院附属中大医院血液科(江苏省医学重点学科)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第5期1289-1292,共4页 Journal of Experimental Hematology
基金 江苏省医学重点学科资助(2011-12)
关键词 BURKITT淋巴瘤 治疗 化疗方案 Burkitt lymphoma therapeutics regimen
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Linch DC. Burkitt lymphoma in adults. Br J Haematol, 2012; 156 (6) :693 -703.
  • 2Kobayashi H, Iehikawa M, Hangaishi A, et al. Concurrent develop- ment of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin. Int J Haema- tol,2011 ;93(1) :112 -117.
  • 3Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lympho- ma. Blood,2004 ; 104 (10) :3009 - 3020.
  • 4于晨,高彦荣.Burkitt淋巴瘤的诊断和治疗进展[J].临床血液学杂志,2010,23(3):317-320. 被引量：11
  • 5Kian TC, Miriam T, Richard Q,et al. Clinical characteristics, prognos- tic factors and outcomes of Burkitt lymphoma in adult Asians. Leuk Lymphoma,2008 ;49 ( 4 ) : 824 - 827.
  • 6Perkins AS, Friedberg JW. Burkitt Lymphoma in Adults. Hematolo- gy Am Soc Hematol Edue Program,2008 ;16:341 -348.
  • 7Cairo MS, Coiffier B, Reiter A, et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haemato1,2010 ; 149 (4) : 578 - 586.
  • 8Rizzieri DA, Johnson JL, Niedzwiecki D, et aL Intensive chemo- therapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of cancer and leukemia group B study 9251. Cancer,2004 ; 100 ( 7 ) : 1438 - 1448.
  • 9Lacasce A, Howard O, Lib S, et al. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphoma: preserved efficacy with decreased toxicity. Leuk Lymphoma, 2004 ;45 (4) :761 - 767.
  • 10Maruyama D, Watanabe T, Maeshima AM, et al. Modified cyclo- phosphamide, vincristine, doxorubicin, and methotrexate ( CODOX- M)/ifosfamide, etoposide,and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermedi- ate between diffuse large B cell lymphoma and BL. Int J Haematol, 2010;92(5) :732 -743.

二级参考文献26

  • 1KIAN T C, MIRIAM T, RICHARD Q, et al. Clinical characteristics, prognostic factors and outcomes of Burkitt lymphoma in adult Asians[J]. Leuk Lymphoma, 2008,49 :. 824- 827.
  • 2PERKINS S L. Work-up and diagnosis of pediatric non-Hodgkin's lymphomas[J]. Pediatr Dev Pathol, 2000,3:374-390.
  • 3OGAWA T, MIZUTANI M, YABANA T, et al. A case of Burkitfs lymphoma involving both breasts[J]. Breast Cancer, 2005,12 : 234- 237.
  • 4DAVE S S,FU K,WRIGHT G W,et al. Molecular diagnosis of Burkitt's lymphoma[J]. N Engl J Med, 2006,354:2431 -2442.
  • 5BLUM K A,LOZANSKI G,BYRD J C. Adult Burkitt leukemia and lymphoma[J]. Blood, 2004,104 : 3009 - 3020.
  • 6PERKINS A S, FRIEDBERG J W. Burkitt lymphoma in adults[J]. Hematology Am Soc Hematol Educ Program, 2008 ~ 341 - 348.
  • 7DIEBOLD J. Burkitt lymphoma [M]//JAFFE E, HARRIS N, STEIN H, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Washington, DC: IARC Press, 2001 : 181 - 184.
  • 8ATTARBASCHI A, MANN G, SCHUMICH A, et al. CD44 deficiency is a consistent finding in childhood Burkitfs lymphoma and leukemia[J]. Leukemia,2007, 21:1110-1113.
  • 9BURMEISTER T, SCHWARTZ S, HORST H A, et al. Molecular heterogeneity of sporadic adult Burkitttype leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features[J]. Leukemia, 2005,19 : 1391 - 1398.
  • 10KANDA K, HUH M, ZHANG I, et al. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer [J]. J Biol Chem, 2000,275 : 32338-32346.

共引文献10

同被引文献63

  • 1孙晓非,甄子俊,刘冬耕,夏奕,向晓娟,陈晓勤,凌家瑜,郑磊,罗文标,林慧,何友兼,管忠震.改良B-NHL-BFM-90方案治疗儿童青少年伯基特淋巴瘤的疗效分析[J].癌症,2007,26(12):1339-1343. 被引量：9
  • 2Jackson Orem,Edward Katongole Mbidde,Bo Lambert,et al.Burkitt's lymphoma in Africa,a review of the epidemiology and etiology.African Health Sciences,2007;7(3):166-175.
  • 3Tanya M.Wildes,Laura Farrington,Cecilia Yeung,et al.Rituximab is associated with improved Survival in Burkitt lymphoma:a retrospective analysis from two US academic medical centers.Therapeutic Advances in Hematology,2014;5(1):3-12.
  • 4Ahmed SO,Sureda A and Aljurf M.The role of hematopoietic SCT in adult Burkitt lymphoma.Bone Marrow Transplantation,2013;48(5):617-629.
  • 5Peniket AJ,Ruiz de Elvira MC,Taghipour G,et al.An EBMT registry matched study of allogeneic stem cell transplants for lymphoma:allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.Bone Marrow Transplant,2003;31(8):667-678.
  • 6Ogwang MD,Bhatia K,Biggar RJ,et al.Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.Int J Cancer,2008;123(11):2658-2663.
  • 7Castillo JJ,Winer ES,Olszewski AJ.Population-based prognostic factors for survival in patients with Burkitt lymphoma:an analysis from the Surveillance,Epidemiology,and End Results database.Cancer,2013;119(20):3672-3679.
  • 8Ewelina Grywalska,Justyna Markowicz,Piotr Grabarczyk,et al.Epstein-Barr virus-associated lymphoproliferative disorders.Postepy Hig Med Dosw(Online),2013;67:481-490.
  • 9Coghill AE,Hildesheim A.Epstein-Barr Virus Antibodies and the Risk of Associated Malignancies:Review of the Literature.American journal of epidemiology,2014;180(7):687-695.
  • 10Crawford DH.Biology and disease associations of Epstein-Barr virus.Philos Trans R Soc Lond B Biol Sci,2001;356(1408):461-473.

引证文献4

二级引证文献19

中国实验血液学杂志
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部